基于影像组学的模型鉴别胶质母细胞瘤与单发脑转移瘤
回顾253例单发脑肿瘤患者(157例胶质母细胞瘤、98例单发脑转移瘤),按7:3分层随机分为训练组178例和验证组77例,提取影像组学特征并用mRMR和LASSO构建模型。训练组和验证组鉴别胶质母细胞瘤与单发脑转移瘤的AUC分别为0.82和0.81,Rad-score在两组均与鉴别诊断显著相关(p<0.001)。
要点
- 影像组学模型在训练组鉴别胶质母细胞瘤与单发脑转移瘤的AUC为0.82。
- 验证组AUC为0.81,提示模型可能有助于术前鉴别诊断。
- Rad-score在训练组和验证组均与鉴别诊断显著相关(p<0.001)。
核心结论
- 影像组学模型可能作为术前鉴别胶质母细胞瘤与单发脑转移瘤的有用支持工具,有助于治疗前决策。
研究设计与样本
- 共纳入253例单发脑肿瘤患者(157例胶质母细胞瘤、98例单发脑转移瘤),按7:3比例用计算机生成的随机数分层抽样分为训练组(n=178)和验证组(n=77)。
诊断标准与关键数值
- 训练组选出11个影像组学特征构建Rad-score;训练组AUC为0.82,验证组AUC为0.81,用于鉴别胶质母细胞瘤与单发脑转移瘤。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
AIM: To differentiate glioblastoma (GBM) from solitary brain metastases (MET) using radiomic analysis.
MATERIALS AND METHODS: Two hundred and fifty-three patients with solitary brain tumours (157 GBM and 98 solitary brain MET) were split into a training cohort (n=178) and a validation cohort (n=77) by stratified sampling using computer-generated random numbers at a ratio of 7:3. After feature extraction, minimum redundancy maximum relevance (mRMR) and the least absolute shrinkage and selection operator (LASSO) were used to build the radiomics signature on the training cohort and validation cohort. Performance was assessed by radiomics score (Rad-score), receiver operating characteristic (ROC) curve, calibration, and clinical usefulness.
RESULTS: Eleven radiomic features were selected as significant features in the training cohort. The Rad-score was significantly associated with the differentiation between GBM and solitary brain MET (p<0.001) both in the training and validation cohorts. The radiomics signature yielded area under the curve (AUC) values of 0.82 and 0.81 in the training and validation cohorts to distinguish between GBM and solitary brain MET.
CONCLUSIONS: The radiomics model might be a useful supporting tool for the preoperative differentiation of GBM from solitary brain MET, which could aid pretreatment decision-making.
引用
- Su CQ, Chen XT, Duan SF, et al. A radiomics-based model to differentiate glioblastoma from solitary brain metastases. Clin Radiol. 2021. PMID: 34092362. doi:10.1016/j.crad.2021.04.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。